Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.

OBJECTIVES The aim of this study was to identify changes in the gene expression profile of Candida albicans associated with the acquisition of experimentally induced resistance to amphotericin B and fluconazole. METHODS C. albicans SC5314 was passed in increasing concentrations of amphotericin B to generate isolate SC5314-AR. Susceptibility testing by Etest revealed SC5314-AR to be highly resistant to both amphotericin B and fluconazole. The gene expression profile of SC5314-AR was compared with that of SC5314 using DNA microarray analysis. Sterol composition was determined for both strains. RESULTS Upon examination of MICs of antifungal compounds, it was found that SC5314-AR was resistant to both amphotericin B and fluconazole. By microarray analysis a total of 134 genes were found to be differentially expressed, that is up-regulated or down-regulated by at least 50%, in SC5314-AR. In addition to the cell stress genes DDR48 and RTA2, the ergosterol biosynthesis genes ERG5, ERG6 and ERG25 were up-regulated. Several histone genes, protein synthesis genes and energy generation genes were down-regulated. Sterol analysis revealed the prevalence of sterol intermediates eburicol and lanosterol in SC5314-AR, whereas ergosterol was the predominant sterol in SC5314. CONCLUSION Along with changes in expression of these ergosterol biosynthesis genes was the accumulation of sterol intermediates in the resistant strain, which would account for the decreased affinity of amphotericin B for membrane sterols and a decreased requirement for lanosterol demethylase activity in membrane sterol production. Furthermore, other genes are implicated as having a potential role in the polyene and azole antifungal resistant phenotype.

[1]  D. Sanglard,et al.  Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents , 2003, Antimicrobial Agents and Chemotherapy.

[2]  K. Barker,et al.  Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[3]  J. Lopez-Ribot,et al.  Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation , 2003, Journal of Clinical Microbiology.

[4]  T. Clark,et al.  Recent trends in the epidemiology of invasive mycoses , 2002, Current opinion in infectious diseases.

[5]  K. Barker,et al.  Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis , 2002, Antimicrobial Agents and Chemotherapy.

[6]  J. Morschhäuser.  The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.

[7]  P. Fidel.  Immunity to Candida. , 2002, Oral diseases.

[8]  A. Barnes,et al.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. , 2002, The Journal of hospital infection.

[9]  J. Lopez-Ribot,et al.  Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. , 2002, The Journal of antimicrobial chemotherapy.

[10]  S. Kelly,et al.  Molecular basis of resistance to azole antifungals. , 2002, Trends in molecular medicine.

[11]  J. Lopez-Ribot,et al.  Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.

[12]  Xiao-Jun Ma,et al.  Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray , 2001, Antimicrobial Agents and Chemotherapy.

[13]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[14]  J. Morschhäuser,et al.  Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. , 2000, The Journal of antimicrobial chemotherapy.

[15]  J. Morschhäuser,et al.  Molecular aspects of fluconazole resistance development in Candida albicans , 1999, Mycoses.

[16]  D. Kelly,et al.  Purification, Reconstitution, and Inhibition of Cytochrome P-450 Sterol Δ22-Desaturase from the Pathogenic Fungus Candida glabrata , 1999, Antimicrobial Agents and Chemotherapy.

[17]  C. Clancy,et al.  Antifungal resistance in non- albicans Candida species. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  D. Kelly,et al.  Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains , 1998, Antimicrobial Agents and Chemotherapy.

[19]  T. C. White,et al.  Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicansIsolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.

[20]  T. C. White,et al.  Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus , 1997, Antimicrobial agents and chemotherapy.

[21]  D. Kelly,et al.  Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation , 1997, FEBS letters.

[22]  J. Wingard,et al.  Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia , 1997, Antimicrobial agents and chemotherapy.

[23]  D. Kelly,et al.  Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients , 1996, The Lancet.

[24]  F. Karst,et al.  Characterization of the Saccharomyces cerevisiae RTA1 gene involved in 7-aminocholesterol resistance , 1996, Current Genetics.

[25]  K. Kuchler,et al.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.

[26]  M. Pfaller,et al.  Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  T. A. Brown,et al.  A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. , 1990, Nucleic acids research.

[28]  R. A. Woods,et al.  Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae. , 1972, Journal of general microbiology.

[29]  E. Anaissie,et al.  New approaches to antifungal chemotherapy. , 1998, Medical mycology.